Skip to content
Search

Latest Stories

APPG report calls for a new 'strategic vision' for community pharmacy

The All-Party Parliamentary Group (APPG) on Pharmacy published a new report on Monday (January 23) that calls for “urgent action” to relieve funding pressure so there are "opportunities" for community pharmacy teams to deliver even more for their patients.

The report highlights the need for a new “strategic vision” for pharmacy and highlights opportunities for the network to be empowered to deliver even more for patients.


However, the manifesto also underlines that there are the very real risks that this opportunity may be lost if significant and ongoing pressures are not addressed.

The recommendations are based on written and oral evidence gathered from frontline pharmacists, GPs, professional bodies and healthcare experts.

To harness the potential of pharmacy, the report recommends the Government must take urgent action to relieve the funding pressures on the community pharmacy sector in the short term and review the long-term funding model for pharmacy.

It also suggested the Government must harness the power of pharmacy to help the NHS deal with the COVID-19 backlog and the UK’s growing healthcare challenges.

It further recommended that future commissioning and funding must recognise that community pharmacy is the front door to the NHS for many patients.

The report said: “The DHSC and NHS England must urgently re-evaluate the current and long-term workforce needs of the entire health and social care system, including pharmacy.”

“The Government should build on current commitments to provide funded independent prescriber training to ensure all existing pharmacists can train as independent prescribers if they so choose. For this ambitious new vision to be realised, community pharmacy must be placed at the heart of decision-making and policy development.”

Chair of the All-Party Parliamentary Group on Pharmacy, Taiwo Owatemi MP, said: “There is a tremendous opportunity for ministers to empower local pharmacies and pharmacy teams to help even more patients and use their skills to support efforts to clear NHS backlogs. But right now pharmacies are being squeezed by a combination of funding and workforce pressures.

"People are often shocked to learn how many local pharmacies are lost each year due to financial pressure. If ever there was a time to properly fund and support our pharmacies it is now.”

Commenting on the report, chair of RPS in England Thorrun Govind said: "This report rightly highlights the need to support a more ambitious approach to advancing the clinical role of pharmacists across the NHS to enhance patient care, including through the growing number of pharmacist independent prescribers.

"Pharmacists and pharmacy teams will play a crucial role in supporting the NHS recovery, reducing health inequalities, managing the growing cost of long-term conditions, and delivering best value from medicines.

"With continued pressure on the health service, it is vital that the pharmacy workforce is supported to keep looking after patients."

NPA chief executive Mark Lyonette said: “This all-party report signals strong support in parliament for pharmacies. A growing number of MPs and peers understand that decent funding is vital to sustain the community pharmacy network and enable an expanded role within the NHS. The solutions the sector is offering to help the NHS get back on its feet cannot come for free, as this cross-party report explicitly recognises.

“The group is also right to pick out workforce planning as key to progress. When community pharmacy becomes a first-thought not an after-thought of workforce planners, NHS capacity will have more hope of keeping up with the ever-increasing demands of our aging population.

NPA board member Olivier Picard said: “I’m glad to be in parliament today to talk to MPs and peers about the future of pharmacy. As pharmacists, we always take a can-do attitude into such meetings, but we also need to be real about the degree of peril many pharmacies are in.

"I am very clear with MPs that funding decisions taken by government in the next months and years can either transform the NHS for the better or put a deep hole in the health service frontline. The government and NHS England need to be thinking in terms of emergency funding as well as a sustainable settlement for the longer term.”

Zoe Long, PSNC Director of Communications and Public Affairs, said: “This report sets out some useful recommendations which we endorse, particularly the call for funding and other support for community pharmacies. We hope Government will take note of what this cross-party group of MPs is telling it and act accordingly, and we will keep working with advocates across Westminster to try to make this happen. Urgent action to relieve the critical funding and other pressures on pharmacies is needed and this is what PSNC is continuing to fight for every day through our Parliamentary, media and wider strategic influencing work.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less